Related Experiment Video
Updated: May 12, 2025

05:59
Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
6.7K
Physical Activity Measurement Reactivity Among Midlife Adults With Elevated Risk for Cardiovascular Disease: Protocol
Kiri Baga1, Gabrielle M Salvatore1, Iris Bercovitz1
1Department of Psychology, Rowan University, Glassboro, NJ, United States.
JMIR Research Protocols
|April 23, 2025
Summary
This study investigates measurement reactivity in physical activity (PA) assessments among adults at risk for cardiovascular disease (CVD). Findings will help refine PA measurement practices for better health research.
Area of Science:
- Public Health
- Epidemiology
- Behavioral Science
Background:
- Cardiovascular disease (CVD) is a leading cause of death in the US.
- Adults aged 40-60 with specific health conditions face elevated CVD risk.
- Accurate physical activity (PA) assessment is crucial for CVD prevention, but measurement reactivity may bias results.
Purpose of the Study:
- To determine the extent of PA measurement reactivity in US adults aged 40-60 with CVD risk factors.
- To identify potential moderators of PA measurement reactivity, such as gender and study expectations.
Main Methods:
- Coordinated multilevel analyses across six studies, including publicly available datasets (NHANES, MIDUS) and behavioral weight loss trials.
- Data from 1832 adults (aged 40-60) with at least one CVD risk factor, encompassing 11,707 days of PA measurement.
- Two-level multilevel models examining daily PA changes and cross-level interactions for moderation effects.
Main Results:
- Dataset acquisition and cleaning completed October 2024.
- Analyses are scheduled for completion by April 2025.
- Findings are expected to be disseminated in July 2025.
Conclusions:
- This project will offer the first large-scale estimation of PA measurement reactivity in a high-risk population.
- Results will guide the development of best practices for PA measurement in clinical trials and observational studies.
- Improved PA assessment can lead to more effective CVD prevention strategies.

